onyx pharmaceuticals inc
(ONXX:NASDAQ GS)

Executive Profile*

Background*

Dr. N. Anthony Coles, Tony, M.D., M.P.H., has been the Chairman of Onyx Pharmaceuticals, Inc. since December 17, 2012 and as its Chief Executive Officer since March 31, 2008. Dr. Coles served as the President of Onyx Pharmaceuticals, Inc since March 31, 2008. He served as the Chief Executive Officer of NPS Pharmaceuticals Inc. from May 11, 2006 to March 17, 2008, Chief Operating Officer from November 2, 2005 to May 11, 2006 and also its President from November 2, 2005 ... to March 17, 2008. Dr. Coles is an accomplished physician and executive leader. He served as Senior Vice President of Commercial Operations-Pharmaceutical Products of Vertex Pharmaceuticals Inc. from March 2002 to November 1, 2005. He served as Head-Global Corporate and Business Development of Vertex Pharmaceuticals Inc. Dr. Coles joined Vertex Pharmaceuticals Inc. in March, 2002. he served as Senior Vice President of Strategy and Policy and Senior Vice President of Marketing and Medical Affairs, Neuroscience/Infectious Diseases/Dermatology at Bristol-Myers Squibb, where he was responsible for overall brand positioning and franchise planning for a $1.8 billion portfolio. He served as Vice President, West Area Sales-Cardiovascular and Metabolic Business Unit for U.S. Primary Care, and Vice President, Cardiovascular Global Marketing of BMS. From 1996 to 2000, he held a variety of senior positions in cardiovascular franchise management and sales at Bristol-Myers Squibb. From 1992 to 1996, Dr. Coles also held a number of positions of increasing responsibility at Merck & Co., Inc., including Vice President of the Hypertension and Heart Failure Business Group. He began his business career at Merck & Co. in 1992, where he had been responsible for strategic marketing initiatives to managed care companies and hospitals and had operational responsibility for a portfolio of cardiovascular drugs. Dr. Coles has been a Director of Onyx Pharmaceuticals, Inc. since March 31, 2008. He served as Director of Laboratory Corp. of America Holdings since January 1, 2011. He served as a Director of Campus Crest Communities, Inc. from October 2010 to April 22, 2013. Dr. Coles is also a member of the board of the Biotechnology Industry Organization (BIO). He has been a Trustee of Johns Hopkins Medicine since July 1, 2010. He serves as a Director of FoldRx Pharmaceuticals Inc. He serves as Trustee for Johns Hopkins University and Boston Medical Center. He has been Member of the board of trustees for The Johns Hopkins Hospital since July 2010. He served as a Director of NPS Pharmaceuticals Inc. from November 02, 2005 to March 17, 2008. He was a Research Fellow at Harvard Medical School. He completed his cardiology and internal medicine training at Massachusetts General Hospital. Dr. Coles holds a Bachelor of Science degree from Johns Hopkins University, a Master's degree in Public Health from Harvard University and a MD degree from Duke University.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
ONXX:US	$95.65 USD	+0.30

COMPETITOR COMPENSATION